Navigation Links
Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
Date:6/21/2012

WESTMINSTER, Colo., June 21, 2012 /PRNewswire/ -- Surefire Medical, Inc. announced today that it has received 510(k) FDA clearance to market the Surefire High-Flow Microcatheter, the next generation of the company's novel infusion technology.  The Surefire system is designed to deliver therapy with higher infusion efficiency than conventional microcatheters.

The Surefire microcatheter's unique expandable tip dynamically expands in reverse flow and collapses in forward flow.

Pre-clinical study results presented at the World Congress of Interventional Oncology (WCIO) in June 2011 found that the Surefire Infusion System achieved an average infusion efficiency of 99.1 % compared to 72.8% with a standard infusion catheter.

In addition, an abstract presented by John Louie, M.D. of Stanford University during the 2012 Annual Scientific Meeting for Society of Interventional Radiology (SIR) stated, "In chemoembolization patients, completion C-arm CT imaging suggested a pattern of increased microsphere tumor penetration and contrast retention. In short term follow-up, no clinical evidence of non-target embolization was observed."

"Working with key interventional radiologists, our research and development team has created a highly trackable, sleek microcatheter designed to accommodate smaller vessels and selective procedures," said Jim Chomas, CEO of Surefire Medical. "The addition of the Surefire High-Flow Microcatheter will enable physicians to treat more patients with addressable disease."

Since launching in August 2011, the initial Surefire Infusion System has been used in 68 high-volume, top-tier hospitals, primarily in interventional procedures to treat primary and secondary liver cancer.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009
'/>"/>

SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
2. Omnyx Share Their Insight on Agile Software Development for Medical Devices
3. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
4. Medical Alarm Lands European Order with Additional Orders Expected
5. Heptares and UK Medical Research Council Extend GPCR Collaboration
6. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
7. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
8. City of Denver and TZ Medical win a Gold Value Chain Award
9. Dehaier Medical Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG
10. Argus Health Systems to Showcase Customizable Product for Medical Drug Claim Compliance at AHIP Institute 2012
11. MMRGlobal and Fujitsu Offer Low-Cost System to Digitize Medical Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... commercialization of a once-daily, oral therapy for the treatment ... it will host a conference call and webcast on ... period ended March 31, 2015 and to provide an ... program for aramchol. Conference Call & ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
(Date:5/6/2015)... 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... for the three-month period ended March 31, 2015. First quarter ... million, an increase of 19% as compared to $7.0 ... Product revenues increased 41% year-over-year, enabled by the return ... Merck Serono in the fourth quarter of 2014; ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
(Date:5/6/2015)... Mesa, Arizona (PRWEB) May 6, ... Ventures, Inc. (MAV), an investor backed Colorado cannabis ... based Phoenician Engineering subsidiary three times since first ... achieved profitability from operations, within one year of ... the end of 2014 to over 500 today ...
(Date:5/6/2015)... The American Water Resources Association (AWRA) announces ... Integrated Water Resources Management (IWRM) award , recognizing excellence in ... , An IWRM approach to water resources has been a ... 12 projects were nominated for the award. The May issue ... 2014 AWRA IWRM Award winner - One Water, One Watershed ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 Doctors ... recently reported what they are calling “unprecedented” tumor control ... article on the new research. Click here to ... gave pembrolizumab to 25 mesothelioma patients between March and ... meeting in April. , “Pembrolizumab… provides robust antitumor activity ...
(Date:5/6/2015)... May 06, 2015 ProTrailer Cartoon Volume ... self-animating generators for Final Cut Pro X . ... titles to a Final Cut Pro X project.It includes ... quality openers to any shot has never been easier. ... in mind, saving users time while adding amazing openers ...
(Date:5/6/2015)... Omaha, NE (PRWEB) May 06, 2015 The ... to a nationwide nursing shortage to an increase in educational ... Aureus Medical Group , offers insight on these trends ... most of the multitude of opportunities that exist in the ... , Widespread electronic health record implementation has been prevalent across ...
Breaking Medicine News(10 mins):Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4
... by Regulatory Approval of Once-Daily Tramadol in, ... for Depression -,LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - Labopharm Inc. ... results for the fourth quarter and year ended December 31, ... , "With our first product about to be rolled out ...
... global rare disease community to raise awareness for underserved ... Feb. 26 Shire Human Genetic Therapies (HGT), a ... company, today announced it will join together with the ... Rare Disease Day on February 28, 2009. The purpose ...
... ST. LOUIS, Feb. 26 Stereotaxis, Inc.,(Nasdaq: ... fourth quarter,ended December 31, 2008. Revenue for the ... 18% over the fourth quarter of 2007. Stereotaxis,recognized ... systems in the quarter. Revenue from sales of ...
... 26 MIND Research Institute today,announced that Jim Mazzo, ... was recently elected to MIND,s board of directors. Mr.,Mazzo ... numerous boards and,committees at the University of California ... of Trustees, the Engineering Advisory Board Committee, and,the Eye ...
... Prestigious AwardsLONDON, Feb. 26 The Healthcare ... Frost & Sullivan,s ,Excellence in Healthcare Awards ... London Zoo, London. The industry,s most influential ... their achievements during an evening dinner gala.(Logo: ...
... Footwear by BeechHUNTINGTON BEACH, Calif., Feb. 26 ... Originals line with new adjustable toe separators ... foot therapy can now be customized to fit ... increasing flexibility and helping improve balance and body ...
Cached Medicine News:Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 2Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 3Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 4Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 5Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 6Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 7Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 8Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 9Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 10Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 11Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 12Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 13Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 14Health News:Shire Celebrates World Rare Disease Day on February 28 2Health News:Shire Celebrates World Rare Disease Day on February 28 3Health News:Shire Celebrates World Rare Disease Day on February 28 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 2Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 3Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 5Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 6Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 7Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Frost & Sullivan Awards to Celebrate Healthcare Excellence 2Health News:Sandal Evolution(R) Takes a Healthy Step 2
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Micro Dissecting Curette, 5 1/2", Round....
14 cm, very delicate, round cupped jaws, straight jaws, 3.0 mm...
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Medicine Products: